Tezted Ltd is innovating the way infectious diseases are diagnosed with a focus on tick-borne diseases and Covid-19. In respect to tick-borne diseases, currently, 80 countries worldwide are reporting people suffering from tick-borne diseases (Lyme Disease, tick-borne encephalitis, etc.) and The World Health Organization (WHO) has indicated that this is only set to increase. 35% of the global population will have Lyme Disease by 2030 and so far it takes 11 different visits and 11 different doctors to get a proper diagnosis. This is outrageous as everyone should have the right to access effective and affordable healthcare. It is time to change this and end this disparity in health care services. In this interesting time with Covid-19, it is important to have efficient antibody based diagnostics to evaluate if individual has been infected with SARS-CoV-2 or have developed an immune response to this respiratory virus. SARSPLEX® offers such a possibility with high diagnostic performance. Te?ted Oy offers CE and IVD registered TICKPLEX® and SARSPLEX® products that test for multiple microbes and multiple disease stages simultaneously at a significant cost reduction for the patient.